FARVET is an innovative biopharmaceutical company, dedicated to the scientific research, development, manufacture and commercialization of a wide range of biological and pharmaceutical products for the animal industry in Peru, Latin America and the world, with the mission of protecting animals from infectious diseases through vaccines.
Our leadership in the vaccine market is based on experience in the veterinary field. Thus, the “know how” of the company is reinforced by the various partners and strategic advisors worldwide and the commitment of our highly trained professionals, which has allowed us to apply a variety of innovative technologies in order to consolidate nationally and insert ourselves commercially in Bolivia, Colombia, Ecuador and Venezuela.
With more than three decades of history, we are a reference company in animal health, especially in biological for poultry and pig farming. Our scientific-commercial expansion plan is to become one of the most important veterinary laboratories specialized in birds and pigs in Latin America, with the capacity to develop products based on research and genomic study of the main diseases of the animal industry. We continually strive to find better solutions for existing or emerging diseases, improving animal health and productivity.
Research is a priority at FARVET, whose activity is aimed at obtaining high-tech products and focuses on the fields of genomics, molecular biology, immunology, microbiology, serology, pharmaceutical technology and diagnostic tests (preclinical and clinical). We believe that animal health must be reflected in science in order for our products and services to protect and improve the lives of animals.
Today, FARVET is ready to face the challenge of maintaining a highly competitive position nationally and internationally in the veterinary sector with the development of innovative and high quality products supported by biotechnological tools for animal health.